David Scheer is Director at Aegerion Pharmaceuticals, Inc. (AEGR). They have made 4 open-market trades across 3 companies since 2010, most recently 2020-01-28.
CIK 0001378585
2 open-market purchases totalling $253K since 2010, against 2 sales. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.